These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

267 related items for PubMed ID: 22875474

  • 1. NSAID enteropathy: could probiotics prevent it?
    Montalto M, Gallo A, Gasbarrini A, Landolfi R.
    J Gastroenterol; 2013 Jun; 48(6):689-97. PubMed ID: 22875474
    [Abstract] [Full Text] [Related]

  • 2. Gut Microbiota in NSAID Enteropathy: New Insights From Inside.
    Wang X, Tang Q, Hou H, Zhang W, Li M, Chen D, Gu Y, Wang B, Hou J, Liu Y, Cao H.
    Front Cell Infect Microbiol; 2021 Jun; 11():679396. PubMed ID: 34295835
    [Abstract] [Full Text] [Related]

  • 3. [NSAID enteropathy].
    Kareva EN.
    Ter Arkh; 2020 Apr 27; 92(2):85-92. PubMed ID: 32598724
    [Abstract] [Full Text] [Related]

  • 4. NSAID enteropathy and bacteria: a complicated relationship.
    Syer SD, Blackler RW, Martin R, de Palma G, Rossi L, Verdu E, Bercik P, Surette MG, Aucouturier A, Langella P, Wallace JL.
    J Gastroenterol; 2015 Apr 27; 50(4):387-93. PubMed ID: 25572030
    [Abstract] [Full Text] [Related]

  • 5. Protective effects of Saccharomyces boulardii CNCM I-745 in an experimental model of NSAID-induced enteropathy.
    Simon O'Brien E, Robert A, Gauthier D, Le Cavorzin A, Planchais J, Roux X, Verleye M, Castagné V.
    Benef Microbes; 2023 Sep 01; 14(3):239-253. PubMed ID: 37646075
    [Abstract] [Full Text] [Related]

  • 6. Prevention and management of non-steroidal anti-inflammatory drugs-induced small intestinal injury.
    Park SC, Chun HJ, Kang CD, Sul D.
    World J Gastroenterol; 2011 Nov 14; 17(42):4647-53. PubMed ID: 22180706
    [Abstract] [Full Text] [Related]

  • 7. Non-steroidal anti-inflammatory drugs-induced small intestinal injury and probiotic agents.
    Guslandi M.
    World J Gastroenterol; 2012 Aug 21; 18(31):4241-2. PubMed ID: 22919262
    [Abstract] [Full Text] [Related]

  • 8. Influence of Microbiota on NSAID Enteropathy: A Systematic Review of Current Knowledge and the Role of Probiotics.
    Rekatsina M, Paladini A, Cifone MG, Lombardi F, Pergolizzi JV, Varrassi G.
    Adv Ther; 2020 May 21; 37(5):1933-1945. PubMed ID: 32291647
    [Abstract] [Full Text] [Related]

  • 9. Review article: a practical approach to the clinical management of NSAID enteropathy.
    Srinivasan A, De Cruz P.
    Scand J Gastroenterol; 2017 Sep 21; 52(9):941-947. PubMed ID: 28587496
    [Abstract] [Full Text] [Related]

  • 10. Psychological stress exacerbates NSAID-induced small bowel injury by inducing changes in intestinal microbiota and permeability via glucocorticoid receptor signaling.
    Yoshikawa K, Kurihara C, Furuhashi H, Takajo T, Maruta K, Yasutake Y, Sato H, Narimatsu K, Okada Y, Higashiyama M, Watanabe C, Komoto S, Tomita K, Nagao S, Miura S, Tajiri H, Hokari R.
    J Gastroenterol; 2017 Jan 21; 52(1):61-71. PubMed ID: 27075753
    [Abstract] [Full Text] [Related]

  • 11. Clinical trial: the effects of a probiotic mixture on non-steroidal anti-inflammatory drug enteropathy - a randomized, double-blind, cross-over, placebo-controlled study.
    Montalto M, Gallo A, Curigliano V, D'Onofrio F, Santoro L, Covino M, Dalvai S, Gasbarrini A, Gasbarrini G.
    Aliment Pharmacol Ther; 2010 Jul 21; 32(2):209-14. PubMed ID: 20384610
    [Abstract] [Full Text] [Related]

  • 12. NSAIDs and the small bowel.
    Tai FWD, McAlindon ME.
    Curr Opin Gastroenterol; 2018 May 21; 34(3):175-182. PubMed ID: 29438118
    [Abstract] [Full Text] [Related]

  • 13. FFA3 Activation Stimulates Duodenal Bicarbonate Secretion and Prevents NSAID-Induced Enteropathy via the GLP-2 Pathway in Rats.
    Said H, Akiba Y, Narimatsu K, Maruta K, Kuri A, Iwamoto KI, Kuwahara A, Kaunitz JD.
    Dig Dis Sci; 2017 Aug 21; 62(8):1944-1952. PubMed ID: 28523577
    [Abstract] [Full Text] [Related]

  • 14. Microbiota Plays a Key Role in Non-Steroidal Anti-Inflammatory Drug-Induced Small Intestinal Damage.
    Otani K, Tanigawa T, Watanabe T, Shimada S, Nadatani Y, Nagami Y, Tanaka F, Kamata N, Yamagami H, Shiba M, Tominaga K, Fujiwara Y, Arakawa T.
    Digestion; 2017 Aug 21; 95(1):22-28. PubMed ID: 28052268
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. NSAID gastropathy and enteropathy: distinct pathogenesis likely necessitates distinct prevention strategies.
    Wallace JL.
    Br J Pharmacol; 2012 Jan 21; 165(1):67-74. PubMed ID: 21627632
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Intestinal permeability in the pathogenesis of NSAID-induced enteropathy.
    Bjarnason I, Takeuchi K.
    J Gastroenterol; 2009 Jan 21; 44 Suppl 19():23-9. PubMed ID: 19148789
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.